Chonnam Med J.  2008 Dec;44(3):117-124. 10.4068/cmj.2008.44.3.117.

Erectile Dysfunction Associated with Psychoactive Substances

• Jiann BP

• KMID: 2172289
• DOI: http://doi.org/10.4068/cmj.2008.44.3.117

Abstract

Psychoactive substances are believed to be aphrodisiac; but in reality they have deleterious effects on all the aspects of sexual function. The purpose of this article is to review and summarize the available scientific literature on the impact of psychoactive substances, including alcohol, tobacco and illicit drugs on erectile dysfunction (ED) in men. Almost all of them have been reported to be associated with ED. These substances may exert their inhibitory effect on erection through their effects on central neurotransmitter pathways (serotogenic, adrenergic or dopaminergic). Besides, some also may exhibit vasoconstricting properties (cocaine), impair endothelium function (nicotine) or suppress the release of luteinizing hormone from the pituitary, resulting in hypogonadism (morphine) to induce ED. The relationship between ED and psychoactive substances is attributed not only to pharmacological effects, but also to psychological and social reactions to substance dependence. Whether withdrawal from the substances could restore erectile function remains unknown. However, human and animal studies demonstrated that the effects of neurological damage from chronic substance abuse are long-lasting. This information of sexual consequence of the substances will be of great general interest and may serve as a powerful tool to healthcare providers.

Keyword

Erectile dysfunction; Psychoacitve drug; Alcohol; Tobacco; Street drugs

MeSH Terms

Animals
Endothelium
Erectile Dysfunction
Health Personnel
Humans
Hypogonadism
Luteinizing Hormone
Male
Neurotransmitter Agents
Street Drugs
Substance-Related Disorders
Tobacco
Luteinizing Hormone
Neurotransmitter Agents
Street Drugs

Reference

1. The world health report 2002: Reducing risks, promoting health life. 2002. Geneva: World Health Organization.

2. Babor TF, Caetano R, Casswell S, Edwards G, Giesbrecht N, Graham K, et al. Alcohol: no ordinary commodity-research and public policy. 2003. Oxford: Oxford University Press.

3. NIH consensus conference. Impotence. NIH consensus development panel on impotence. JAMA. 1993. 270:83–90.

4. Burnett AL, Lowenstein CJ, Bredt DS, Chang TS, Snyder SH. Nitric oxide: a physiologic mediator of penile erection. Science. 1992. 257:401–403.

5. Bredt DS, Hwang PM, Glatt CE, Lowenstein C, Reed RR, Snyder SH. Cloned and expressed nitric oxide synthase structurally resemble cytochrome P-450 reductase. Nature. 1991. 351:714–718.

6. Lyons CR, Orloff GJ, Cunningham JM. Molecular cloning and functional expression of an inducible nitric oxide synthase from a murine macrophage cell line. J Biol Chem. 1992. 267:6370–6374.

7. Lamas S, Marsden PA, Li GK, Tempst P, Michel T. Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform. Proc Natl Acad Sci U S A. 1992. 89:6348–6352.

8. Snyder SH, Jaffrey SR. Vessels vivified by Akt acting on NO synthase. Nat Cell Biol. 1999. 1:E95–E96.

9. Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, Zeiher AM. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature. 1999. 399:601–605.

10. McVary KT, Carrier S, Wessells H. Subcommittee on Smoking and Erectile Dysfunction Socioeconomic Committee, Sexual Medicine Society of North America. Smoking and erectile dysfunction: evidence based analysis. J Urol. 2001. 166:1624–1632.

11. Adachi H, Sato Y, Kato R, Hisasue S, Suzuki K, Masumori N, et al. Direct evidence of facilitative actions of dopamine in the medial preoptic area on reflexive and noncontact erections in male rats. J Urol. 2003. 169:386–389.

12. Holmes GM, Bresnahan JC, Beattie MS. Inhibition of pudendal reflexes in spinal rats. Reassessing the role of serotonin. Physiol Behav. 2001. 74:57–64.

13. Traish A, Kim N. The physiological role of androgens in penile erection: regulation of corpus cavernosum structure and function. J Sex Med. 2005. 2:759–770.

14. Meinhardt W, Kropman RF, Vermeij P, Nijeholt AA, Zwartendijk J. The influence of medication on erectile function. Int J Impot Res. 1997. 9:17–26.

15. Pollack MH, Reiter S, Hammerness P. Genitourinary and sexual adverse effects of psychotropic medication. Int J Psychiatry Med. 1992. 22:305–327.

16. Horowitz JD, Goble AJ. Drugs and impaired male sexual function. Drugs. 1979. 18:206–217.

17. Mirin SM, Meyer RE, Mendelson JH, Ellingboe J. Opiate use and sexual function. Am J Psychiatry. 1980. 137:909–915.

18. Millar JG. Drug-induced impotence. Practitioner. 1979. 223:634–639.

19. Rosen RC. Alcohol and drug effects on sexual response: human experimental and clinical studies. Ann Rev Sex Res. 1991. 2:119–179.

20. McKay A. Sexuality and substance use: the impact of tobacco, alcohol and selected recreational drugs on sexual function. Can J Hum Sex. 2005. 14:47–56.

21. Jacobs MR, Fehr KOB. Drugs and drug abuse: a reference text. 1987. 2nd ed. Toronto: Addiction Research Foundation.

22. McBride WJ. Central nucleus of the amygdala and the effects of alcohol and alcohol-drinking behavior in rodents. Pharmacol Biochem Behav. 2002. 71:509–515.

23. Grobin AC, Matthews DB, Devaud LL, Morrow AL. The role of GABA(A) receptors in the acute and chronic effects of ethanol. Psychopharmacology (Berl). 1998. 139:2–19.

24. Wang GJ, Volkow ND, Franceschi D, Fowler JS, Thanos PK, Scherbaum N, et al. Regional brain metabolism during alcohol intoxication. Alcohol Clin Exp Res. 2000. 24:822–829.

25. Nordmann R, Ribière C, Rouach H. Ethanol-induced lipid peroxidation and oxidative stress in extrahepatic tissues. Alcohol. 1990. 25:231–237.

26. Rivier C, Rivest S, Vale W. Alcohol-induced inhibition of LH secretion in intact and gonadectomized male and female rats: possible mechanisms. Alcohol Clin Exp Res. 1992. 16:935–941.

27. O'Farrell TJ, Kleinke CL, Cutter HS. Sexual adjustment of male alcoholics: changes from before to after receiving alcoholism counseling with and without marital therapy. Addict Behav. 1998. 23:419–425.

28. Mandell W, Miller CM. Male sexual dysfunction as related to alcohol consumption: a pilot study. Alcohol Clinic Exp Res. 1983. 7:65–69.

29. Snyder S, Karacan I. Effects of chronic alcoholism on nocturnal penile tumescence. Psychosom Med. 1981. 43:423–429.

30. Fahrner EM. Sexual dysfunction in male alcohol addicts: prevalence and treatment. Arch Sex Behav. 1987. 16:247–257.

31. Lemere F, Smith JW. Alcohol-induced sexual impotence. Am J Psychiatry. 1973. 130:212–213.

32. Mackay J, Eriksen M. The tobacco atlas. 2002. Geneva: World Health Organization.

33. Foulds J, Stapleton JA, Bell N, Swettenham J, Jarvis MJ, Russell MA. Mood and physiological effects of subcutaneous nicotine in smokers and never-smokers. Drug Alcohol Depend. 1997. 44:105–115.

34. Sullivan ME, Keoghane SR, Miller MA. Vascular risk factors and erectile dysfunction. BJU Int. 2001. 87:838–845.

35. Wolf R, Shulmam A. Erectile dysfunction and fertility related to cigarette smoking. J Eur Acad Dermatol Venereol. 1996. 6:209–216.

36. Tengs TO, Osgood ND. The link between smoking and impotence: two decades of evidence. Prev Med. 2001. 32:447–452.

37. Feldman HA, Johannes CB, Derby CA, Kleinman KP, Mohr BA, Araujo AB, et al. Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts male aging study. Prev Med. 2000. 30:328–338.

38. Bortolotti A, Fedele D, Chatenoud L, Colli E, Coscelli C, Landoni M, et al. Cigarette smoking: a risk factor for erectile dysfunction in diabetics. Eur Urol. 2001. 40:392–396.

39. Mirone V, Imbimbo C, Bortolotti A, Di Cintio E, Colli E, Landoni M, et al. Cigarette smoking as a risk for erectile dysfunction: results from an Italian epidemiological study. Eur Urol. 2002. 41:294–297.

40. Peugh J, Belenko S. Alcohol, drugs and sexual function: a review. J Psychoactive Drugs. 2001. 33:223–232.

41. Donatucci CF, Lue TF. Erectile dysfunction in men under 40: etiology and treatment choice. Int J Impot Res. 1993. 5:97–103.

42. Palha AP, Esteves M. A study of the sexuality of opiate addicts. J Sex Marital Ther. 2002. 28:427–437.

43. Brownstein MJ. A brief history of opiates, opioid peptides and opioid receptors. Proc Natl Acad Sci U S A. 1993. 90:5391–5393.

44. Jaffe JH. Gilman AG, Rall TW, Njes AS, Taylor P, editors. Drug addiction and drug abuse. Goodman and Gilman's the pharmacological basis of therapeutics. 1990. 8th ed. New York: Pergamon Press;522–573.

45. Mansour A, Fox CA, Akil H, Watson SJ. Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci. 1995. 18:22–29.

46. Pasternak GW. Pharmacological mechanisms of opioid analgesics. Clin Neuropharmacol. 1993. 16:1–18.

47. Jaffe JH, Knapp CM, Ciraulo DA. Lowinson JH, Ruiz P, Millman RB, Langrod JG, editors. Opiates: clinical aspects. Substance abuse: a comprehensive textbook. 1997. 3rd ed. Baltimore, Maryland: Williams & Willkins.

48. Cushman P Jr. Sexual behavior in heroin addiction and methadone maintenance. Correlation with plasma luteinizing hormone. N Y State J Med. 1972. 72:1261–1265.

49. Mintz J, O'Hare K, O'Brien CP, Goldschmidt J. Sexual problems of heroin addicts. Arch Gen Psychiatry. 1974. 31:700–703.

50. Bang-Ping J. Sexual dysfunction in men who abuse illicit drugs: a preliminary report. J Sex Med. 2007.

51. Roberts L, Finch PM, Pullan PT, Bhagat CI, Price LM. Sex hormone suppression by intrathecal opioids: a prospective study. Clin J Pain. 2002. 18:144–148.

52. Smith DE, Moser C, Wesson DR, Apter M, Buxton ME, Davison JV, et al. A clinical guide to the diagnoses and treatment of heroin-related sexual dysfunction. J Psychoactive Drugs. 1982. 14:91–99.

53. Hallinan R, Byrne A, Agho K, McMahon C, Tynan P, Attia J. Erectile dysfunction in men receiving methadone and buprenorphine maintenance treatment. J Sex Med. 2008. 5:684–692.

54. Volkow ND, Chang L, Wang GJ, Fowler JS, Ding YS, Sedler M, et al. Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. Am J Psychiatry. 2001. 158:2015–2021.

55. Volkow ND, Chang L, Wang GJ, Fowler JS, Leonido-Yee M, Franceschi D, et al. Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am J Psychiatry. 2001. 158:377–382.

56. Hirshfiled S, Remien RH, Walavalkar I, Chiasson MA. Crystal methamphetamine use predicts incident STD infection among men who have sex with men recruited online: a nested case-control study. J Med Internet Res. 2004. 6:e41.

57. Shaper AG. Walking on the moon. Lancet. 1996. 347:207–208.

58. Steele TD, McCann UD, Ricaurte GA. 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy"): pharmacology and toxicology in animals and humans. Addiction. 1994. 89:539–551.

59. Schiavi RC, Segraves RT. The biology of sexual function. Psychiatr Clin North Am. 1995. 18:7–23.

60. Palha AP, Esteves M. Drugs of abuse and sexual functioning. Adv Psychosom Med. 2008. 29:131–149.

61. Kalant H. The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs. CMAJ. 2001. 165:917–928.

62. Zemishlany Z, Aizenberg D, Weizman A. Subjective effects of MDMA ('Ecstasy' on human sexual function. Eur Psychiatry. 2001. 16:127–130.

63. Buffum J, Moser C. MDMA and human sexual function. J Psychoactive Drugs. 1986. 18:355–359.

64. Ritz MC, Cone EJ, Kuhar MJ. Cocaine inhibition of ligand binding at dopamine, norepinephrine and serotonin transporters: a structureactivity study. Life Sci. 1990. 46:635–645.

65. Buffum J. Pharmacolosexology: the effects of drugs on sexual function: a review. J Psychoactive Drugs. 1982. 14:5–44.

66. Buffum J, Moser C, Smith D. Sisten JMA, editor. Street drugs and sexual function. Handbook of sexology. 1988. Volume 6: the pharmacology and endocrinology of sexual function. New York: Elsevier Science Publishers.

67. MacDonald PT, Waldorf D, Reinarman C, Murphy S. Heavy cocaine use and sexual behavior. J Drug Issues. 1988. 18:437–455.

68. Saso L. Effects of drug abuse on sexual response. Ann Ist Super Sanità. 2002. 38:289–296.

69. Mireku-Boateng AO, Tasie B. Priapism associated with intracavernosal injection of cocaine. Urol Int. 2001. 67:109–110.

70. Adams IB, Martin BR. Cannabis: pharmacology and toxicology in animals and humans. Addiction. 1996. 91:1585–1614.

71. Halikas J, Weller R, Morse C. Effects of regular marijuana use on sexual performance. J Psychoactie Drugs. 1982. 14:59–70.

72. UNODCCP Global illicit drug trends. 2002. New York, NY: United Nations Office for Drug Control and Crime Prevention.

73. Holden GA, McLachlan RI, Pitts M, Cumming R, Wittert G, Agius PA, et al. Men in Australia Telephone Survey (MATeS): a national survey of the reproductive health and concerns of middle-aged and older Australian men. Lancet. 2005. 366:218–224.